Calidi Biotherapeutics Long Term Debt

Calidi Biotherapeutics (CLDI) currently reports a long-term debt of $170K as of June 2026. That compares with $2.4M in the prior-year period — down 93.2% year over year. Use the charts on this page to explore Calidi Biotherapeutics's long-term debt history and peer comparisons.

Calidi Biotherapeutics's long-term debt decreased from $2.4M to $170K — a 93.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calidi Biotherapeutics reported $170K in long-term debt as of June 2026. That compares with $2.4M in the prior-year period — down 93.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calidi Biotherapeutics, and consider following CLDI for alerts when major investors trade the stock.